The RNAscope in situ hybridization (ISH) technology is a powerful method for detecting gene expression with spatial and morphological tissue context. In this webinar, we will focus on an Integrated Co ...
An integrated assay using proprietary RNAscope™ and miRNAscope™ technologies to measure the biodistribution and function of novel gene therapies and endogenous regulatory RNAs. Small regulatory RNAs, ...
(RTTNews) - Bio-Techne (TECH), a US-based biotechnology company Thursday has introduced an expanded range of human and mouse RNAscope in situ hybridization probes to support spatial biology research ...
MINNEAPOLIS, March 24, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced further advancements in its ongoing strategy to bring translational discoveries to patient care by ...
In this webinar we will provide an overview of RNAscope™ ISH technology, then discuss our new RNAscope multiomic applications coming soon. RNAscope is the gold standard for RNA ISH -providing ...
Bio-Techne has added new capabilities and options to its Advanced Cell Diagnostics (ACD)-branded RNAscope® and BaseScope™ in situ hybridization (ISH) Assay Services Portfolio to improve biotech and ...
Advanced Cell Diagnostics (ACD), a company recently acquired by Bio-Techne, has introduced assays that promise to transform molecular pathology. These assays can detect and quantify RNA in situ while ...
Results from using RNAscope technology to detect novel truncated RNAs in the aging human brain created by the “jumping” of long interspersed nuclear element-1, a genetic sequence known to use its own ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results